Sadiya Rokerya

Associate Director, Development Quality Risk Strategy (r&d) - Astrazeneca Rare Disease at Alexion Pharmaceuticals

Sadiya Rokerya, CQA, CCRP(c), B.Sc., currently serves as the Associate Director of Development Quality Risk Strategy for AstraZeneca Rare Disease at Alexion Pharmaceuticals, Inc., since April 2023, after holding the role of Senior Manager in the same department. Prior to this, Sadiya accumulated extensive experience at Bayshore HealthCare from February 2016 to April 2023 in various roles, including Manager of Scientific Affairs focusing on Drug Safety & Quality and Lead of Quality Compliance. Earlier experience includes working as a Sterilization Specialist and Office Assistant for Dr. Lisa Bentley. Sadiya holds a Post-Graduate Certificate in Clinical Research from The Michener Institute and a Bachelor of Science degree in Biomedical Sciences from the University of Guelph.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices